Hyperprolactinemia

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Hyperprolactinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperprolactinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocaridography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperprolactinemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperprolactinemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperprolactinemia

CDC on Hyperprolactinemia

Hyperprolactinemia in the news

Blogs on Hyperprolactinemia

Directions to Hospitals Treating Hyperprolactinemia

Risk calculators and risk factors for Hyperprolactinemia

Synonyms and keywords: Hyperprolactinaemia; Ahumada-DelCastillo syndrome; Chiari-Frommel syndrome; Forbes-Albright syndrome

For patient information click here

Hyperprolactinemia
ICD-10 E22.1
ICD-9 253.1
DiseasesDB 6314
MeSH D006966

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperprolactinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Acknowledgements

The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.

References

Template:WS Template:WH